Finckh, Axel

Title Year Hits Downloads
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis 2017 10 0
The role of female hormonal factors in the development of rheumatoid arthritis 2017 33 0
Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life 2017 61 1
Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype 2017 39 15
New viral outbreaks: time for rheumatologists to get involved? 2017 12 0
Environmental factors and hormones in the development of rheumatoid arthritis 2017 9 0
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis 2017 10 0
Value of Biomarkers in the Prevention of Rheumatoid Arthritis 2017 12 0
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study 2016 14 4
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis 2016 120 0
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative 2016 14 0
Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis 2016 14 0
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report 2016 302 7
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis 2016 23 0
Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences 2016 72 1
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study 2015 109 53
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry 2015 87 0
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial 2015 184 0
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis 2015 121 0
An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks 2015 117 0
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria 2015 158 0
The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers 2015 161 58
The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis 2015 112 0
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study 2015 185 0
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries 2015 47 30
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study 2015 94 0
Facteurs de risque pour le développement d’une polyarthrite rhumatoïde 2014 175 2
The impact of obesity on the development and progression of rheumatoid arthritis 2014 155 0
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee 2014 147 0
Immune-mediated experimental arthritis in IL-33 deficient mice 2014 194 1
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial 2014 213 0
Prevention of rheumatic diseases: strategies, caveats, and future directions 2014 149 0
Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? 2014 95 0
Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study 2014 172 92
Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK. 2014 179 271
Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study 2014 158 0
The importance of early treatment for the prognosis of rheumatoid arthritis 2013 192 52
Complications cardio-vasculaires dans les maladies auto-immunes 2013 164 1
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency 2013 209 58
Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk population 2013 131 0
Do synovial leptin levels correlate with pain in end stage arthritis? 2013 221 1
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry 2013 154 0
Smoking and spondyloarthritis 2013 151 1
Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis 2012 263 0
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists 2012 148 203
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis 2012 258 416
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients 2012 196 0
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial 2012 234 0
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? 2012 230 1
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis 2011 191 1
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion 2011 127 1
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study 2011 189 0
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection 2011 192 0
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center 2011 185 0
Patient repositioning reproducibility of joint space with (JSW) measurements on hand radiographs 2011 121 0
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis 2011 195 0
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients 2010 195 0
Comparative effectiveness of rheumatoid arthritis therapies 2010 116 0
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology 2010 173 0
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries 2010 194 0
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients 2010 223 309
Cost-effectiveness of biologics in early rheumatoid arthritis 2010 181 0
Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis 2010 190 0
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis 2010 221 1
The effect of alcohol on radiographic progression in rheumatoid arthritis 2010 193 0
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? 2010 174 0
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial 2010 202 0
Osteoarthritis: Small studies overestimate the benefit of therapies for OA 2010 288 0
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies 2009 234 151
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis 2009 199 1
BMI and severity of clinical and radiographic signs of hip osteoarthritis 2009 186 0
The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study 2009 147 7
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis 2009 183 0
Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation 2009 210 67
Primer: strengths and weaknesses of meta-analysis 2008 185 1
Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial 2008 130 1
Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc 2008 196 0
At the horizon of innovative therapy in rheumatology: new biologic agents 2008 184 9
Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management 2004 44 0
Neurophysiologic evidence for a central sensitization in patients with fibromyalgia 2003 55 77
11811 1894